| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Hull Andrew is a Director at InMed Pharmaceuticals Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $57K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | INM Inmed Pharmaceuticals Inc. | Director | Buy | 37,500 | $0.39 | $14,625.00 | +4,947% | -18.4% | -58.0% |